Wilde, C
Lakshmanan, A
Patel, M
Morales, M U
Dhar-Munshi, S
Amoaku, W M K
Article History
Received: 2 October 2015
Accepted: 21 January 2016
First Online: 1 April 2016
Competing interests
: Professor Winfried Amoaku, MBChB, has disclosed the following relevant financial relationships: Served as an advisor or consultant for: Alcon Laboratories, Inc.; Alimera Sciences; Allergan, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; Pfizer Inc; Roche; ThromboGenics, Inc. Served as a speaker or a member of the speaker's bureau for: Alimera Sciences; Allergan, Inc.; Novartis Pharmaceuticals Corporation; Pfizer. Received grants for clinical research from: Allergan, Inc.; CenterVue; Novartis Pharmaceuticals Corporation; Pfizer. Other (Educational Travel Grants): Allergan, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation. The remaining authors declare no conflict of interest.